- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Ashish K. Jha Addresses WHO's Reaction to the Zika Virus
Ashish K. Jha, MD, MPH, discusses how the World Health Organization and other public health agencies are handling the Zika virus, and what role the media plays in their responses to global pandemics.
Ashish K. Jha, MD, MPH, discusses how the World Health Organization and other public health agencies are handling the Zika virus, and what role the media plays in their responses to global pandemics.
Transcript (modified)
In the past you spoke out about how the World Health Organization handled the Ebola crisis. Now WHO has declared the Zika virus an international public health crisis. Has there been an improvement in how WHO handles these types of situations?
The Zika virus comes right on the heels of the catastrophe that was our response to Ebola. And Ebola really was a terrible lesson about how the world failed to respond effectively, and so the World Health Organization—lots of public health agencies—are under the microscope to get Zika right.
The good news is Zika is not as easily transmittable; it’s not quite as deadly as Ebola. But that all said, I do think WHO has acted more quickly, I do think other public health agencies are moving more quickly. The real question is: This urgency we see now, will it still be there when the media spotlight goes away in a few years?
The next big pandemic may not come when everybody is paying attention. And the question at that point will be: Will WHO and other public health agencies and countries respond quickly and effectively or do they need the media spotlight to do it?
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
